PrecisionTAVI (v1.1)
Interventional Cardiovascular Implant Simulation Software Device. 510(k) K223809, from Dasi Simulations (Dublin, OH). Product code QQI, class 2.
As of Nov 21, 2026, K223809 is an FDA 510(k) held by Dasi Simulations, substantially equivalent on May 30, 2023 after 161 days, with no recalls tied to it in FDA's recall database.
- Review time: 161 days
- Recalls: 0
PrecisionTAVI is an optional, non-invasive, post processing software solution that is indicated for patient-specific simulations ofTranscatheter Aortic Valve Replacement (TAVR) during procedural planning. The software performs computer simulation to predict post TAVR in vivo valve frame deformation of clinician selected Transcatheter Heart Valve (THV) device types and sizes.
- FEops HEARTguideK214066 · Feops NV · Feb 25, 2022
- FEops HEARTguide Simulation ApplicationK250635 · Feops NV · Nov 25, 2025
- FEops HEARTguideK214066 · Feops NV · Feb 25, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 20, 2022
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1405
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files